Aleksunes LM - Search Results

1

Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy.

George B, Joy MS, Aleksunes LM. George B, et al. Among authors: aleksunes lm. Exp Biol Med (Maywood). 2018 Feb;243(3):272-282. doi: 10.1177/1535370217745302. Epub 2017 Dec 12. Exp Biol Med (Maywood). 2018. PMID: 29231123 Free PMC article. Review.

2

Activation of NRF2 Signaling in HEK293 Cells by a First-in-Class Direct KEAP1-NRF2 Inhibitor.

Wen X, Thorne G, Hu L, Joy MS, Aleksunes LM. Wen X, et al. Among authors: aleksunes lm. J Biochem Mol Toxicol. 2015 Jun;29(6):261-6. doi: 10.1002/jbt.21693. Epub 2015 Feb 12. J Biochem Mol Toxicol. 2015. PMID: 25683455 Free PMC article.

3

Bardoxolone methyl modulates efflux transporter and detoxifying enzyme expression in cisplatin-induced kidney cell injury.

Atilano-Roque A, Aleksunes LM, Joy MS. Atilano-Roque A, et al. Among authors: aleksunes lm. Toxicol Lett. 2016 Sep 30;259:52-59. doi: 10.1016/j.toxlet.2016.07.021. Epub 2016 Jul 29. Toxicol Lett. 2016. PMID: 27480280

4

Profiling of Kidney Injury Biomarkers in Patients Receiving Cisplatin: Time-dependent Changes in the Absence of Clinical Nephrotoxicity.

George B, Wen X, Mercke N, Gomez M, O'Bryant C, Bowles DW, Hu Y, Hogan SL, Joy MS, Aleksunes LM. George B, et al. Among authors: aleksunes lm. Clin Pharmacol Ther. 2017 Apr;101(4):510-518. doi: 10.1002/cpt.606. Epub 2017 Feb 14. Clin Pharmacol Ther. 2017. PMID: 28002630 Free PMC article.

5

Xenobiotic transporters and kidney injury.

George B, You D, Joy MS, Aleksunes LM. George B, et al. Among authors: aleksunes lm. Adv Drug Deliv Rev. 2017 Jul 1;116:73-91. doi: 10.1016/j.addr.2017.01.005. Epub 2017 Jan 20. Adv Drug Deliv Rev. 2017. PMID: 28111348 Free PMC article. Review.

6

In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants.

Wen X, Joy MS, Aleksunes LM. Wen X, et al. Among authors: aleksunes lm. Pharm Res. 2017 Aug;34(8):1637-1647. doi: 10.1007/s11095-017-2160-0. Epub 2017 Apr 12. Pharm Res. 2017. PMID: 28405913 Free PMC article.

7

Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin.

Chang C, Hu Y, Hogan SL, Mercke N, Gomez M, O'Bryant C, Bowles DW, George B, Wen X, Aleksunes LM, Joy MS. Chang C, et al. Among authors: aleksunes lm. Int J Mol Sci. 2017 Jun 22;18(7):1333. doi: 10.3390/ijms18071333. Int J Mol Sci. 2017. PMID: 28640195 Free PMC article.

8

Nrf2 activators as potential modulators of injury in human kidney cells.

Atilano-Roque A, Wen X, Aleksunes LM, Joy MS. Atilano-Roque A, et al. Among authors: aleksunes lm. Toxicol Rep. 2016 Jan 12;3:153-159. doi: 10.1016/j.toxrep.2016.01.006. eCollection 2016. Toxicol Rep. 2016. PMID: 28959534 Free PMC article.

9

Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patients.

Ibrahim ME, Chang C, Hu Y, Hogan SL, Mercke N, Gomez M, O'Bryant CL, Bowles DW, George B, Wen X, Buckley B, Aleksunes L, Joy MS. Ibrahim ME, et al. Eur J Clin Pharmacol. 2019 Jan;75(1):51-57. doi: 10.1007/s00228-018-2552-z. Epub 2018 Sep 15. Eur J Clin Pharmacol. 2019. PMID: 30220072 Free PMC article.

10

Time-dependent changes in kidney injury biomarkers in patients receiving multiple cycles of cisplatin chemotherapy.

George B, Wen X, Mercke N, Gomez M, O'Bryant C, Bowles DW, Hu Y, Hogan SL, Joy MS, Aleksunes LM. George B, et al. Among authors: aleksunes lm. Toxicol Rep. 2020 Apr 22;7:571-576. doi: 10.1016/j.toxrep.2020.04.003. eCollection 2020. Toxicol Rep. 2020. PMID: 32382514 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters